InvestorsHub Logo
Followers 80
Posts 6910
Boards Moderated 0
Alias Born 07/30/2006

Re: None

Wednesday, 11/16/2016 6:03:44 PM

Wednesday, November 16, 2016 6:03:44 PM

Post# of 2676

Cannabinoid Drug Advancements Take Off After Quantum Shift in U.S. Drug
ZYNERBA PHARMACEUTICALS, INC. (NASDAQ:ZYNE)


Increased funding due to overall market momentum is serving to aid biotech and pharma companies within medicinal cannabis sector to delve deeper into the research and development of cannabinoid prodrug pharmaceutical solutions.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ZYNE News